Substantial in vivo tumour growth suppression with low toxicity; downregulated nuclear factor-κB and BCL-2 expression; inhibited expression of P-glycoprotein, MrP-1, BCRP, and triggered apoptosis. Here, BCL2 is linked to neoplasm.